Vaxcyte (PCVX) Cash & Current Investments (2019 - 2026)
Vaxcyte (PCVX) reported Cash & Current Investments of $1.29 billion for Q3 2026, down 24.5% from $1.71 billion a year earlier and down 13.1% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte posted Cash & Current Investments of $1.56 billion, down 10.7% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 32.2% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $1.75 billion in FY2024 (+61.7%), $1.08 billion in FY2023 (+16.0%), $931.38 million in FY2022 (+278.7%) and $245.97 million in FY2021 (-36.3%).
- The Q3 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q4 2023.
- Year over year, Cash & Current Investments gained in four of the last eight quarters, with growth averaging 3.2%.
- The high point for year-over-year Cash & Current Investments in five years was Q4 2022 (growth of 278.7%); the low point was Q4 2021 (a decline of 36.3%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.49 billion (Q2 2026), $1.74 billion (Q1 2026) and $1.56 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Vaxcyte | 9.91 Bn | 3.83 Bn | - | 1.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.29 Bn |
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.74 Bn |
| Dec 31, 2025 | 1.56 Bn |
| Sep 30, 2025 | 1.71 Bn |
| Jun 30, 2025 | 1.66 Bn |
| Mar 31, 2025 | 1.67 Bn |
| Dec 31, 2024 | 1.75 Bn |
| Sep 30, 2024 | 2.18 Bn |
| Jun 30, 2024 | 1.45 Bn |
| Mar 31, 2024 | 1.49 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.29 Bn |
| Mar 31, 2023 | 822.04 Mn |
| Dec 31, 2022 | 931.38 Mn |
| Sep 30, 2022 | 362.23 Mn |
| Jun 30, 2022 | 354.50 Mn |
| Mar 31, 2022 | 334.64 Mn |
| Dec 31, 2021 | 245.97 Mn |
API Access
Vaxcyte Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();